Human papillomaviruses (HPV) cause several serious and life-threatening diseases, with cervical cancer having received the most attention. In recent years, effective vaccines protecting against the most high-risk HPV types have become available and are now provided to populations in many high-income countries. However, in low- and middle-income countries HPV vaccines are much less widely available at present, and in these settings population screening for cervical cancer and its precursors may also be absent.
In this month’s Editorial, Karin Sundström and Miriam Elfström discuss plans to roll-out HPV vaccines for prevention of cervical cancer and other diseases more generally, and consider the longer-term prospects for cervical cancer elimination.
Image Credit: Hey Paul Studios, Flickr
Editorial
Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
PLOS Medicine: published January 28, 2020 | https://doi.org/10.1371/journal.pmed.1003035
Perspective
Isoniazid-resistant tuberculosis: A problem we can no longer ignore
PLOS Medicine: published January 21, 2020 | https://doi.org/10.1371/journal.pmed.1003023
Related Articles
Policy Forum
Infectious disease pandemic planning and response: Incorporating decision analysis
PLOS Medicine: published January 9, 2020 | https://doi.org/10.1371/journal.pmed.1003018
Research Articles
Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: A cluster randomised controlled trial
PLOS Medicine: published January 2, 2020 | https://doi.org/10.1371/journal.pmed.1002997
Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis
PLOS Medicine: published January 6, 2020 | https://doi.org/10.1371/journal.pmed.1003017
The association of depression with subsequent dementia diagnosis: A Swedish nationwide cohort study from 1964 to 2016
PLOS Medicine: published January 9, 2020 | https://doi.org/10.1371/journal.pmed.1003016
Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses
PLOS Medicine: published January 15, 2020 | https://doi.org/10.1371/journal.pmed.1003013
Potential gains in life expectancy by attaining daily ambient fine particulate matter pollution standards in mainland China: A modeling study based on nationwide data
PLOS Medicine: published January 17, 2020 | https://doi.org/10.1371/journal.pmed.1003027
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
PLOS Medicine: published January 21, 2020 | https://doi.org/10.1371/journal.pmed.1003008
Related Articles
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
PLOS Medicine: published January 24, 2020 | https://doi.org/10.1371/journal.pmed.1003012
Related Articles
Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study
PLOS Medicine: published January 31, 2020 | https://doi.org/10.1371/journal.pmed.1003019